These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29930482)

  • 1. Integrin β1 regulates the invasion and radioresistance of laryngeal cancer cells by targeting CD147.
    Li L; Dong X; Peng F; Shen L
    Cancer Cell Int; 2018; 18():80. PubMed ID: 29930482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HAb18G/CD147 promotes radioresistance in hepatocellular carcinoma cells: a potential role for integrin β1 signaling.
    Wu J; Li Y; Dang YZ; Gao HX; Jiang JL; Chen ZN
    Mol Cancer Ther; 2015 Feb; 14(2):553-63. PubMed ID: 25534361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular membrane-proximal domain of HAb18G/CD147 binds to metal ion-dependent adhesion site (MIDAS) motif of integrin β1 to modulate malignant properties of hepatoma cells.
    Li Y; Wu J; Song F; Tang J; Wang SJ; Yu XL; Chen ZN; Jiang JL
    J Biol Chem; 2012 Feb; 287(7):4759-72. PubMed ID: 22130661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing profilin-1 inhibits gastric cancer progression via integrin β1/focal adhesion kinase pathway modulation.
    Cheng YJ; Zhu ZX; Zhou JS; Hu ZQ; Zhang JP; Cai QP; Wang LH
    World J Gastroenterol; 2015 Feb; 21(8):2323-35. PubMed ID: 25741138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The expression and significance of integrin beta1 and focal adhesion kinase and its clinical value in laryngeal carcinoma].
    Wei G; Du Y; Yang C; Zhang X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Dec; 22(24):1112-4. PubMed ID: 19297850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of C1GalT1 inhibits radioresistance of human esophageal cancer cells through modifying β1-integrin glycosylation.
    Zhang C; Deng X; Qiu L; Peng F; Geng S; Shen L; Luo Z
    J Cancer; 2018; 9(15):2666-2677. PubMed ID: 30087707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered O-glycosylation is associated with inherent radioresistance and malignancy of human laryngeal carcinoma.
    Dong X; Luo Z; Wang Y; Meng L; Duan Q; Qiu L; Peng F; Shen L
    Exp Cell Res; 2018 Jan; 362(2):302-310. PubMed ID: 29179977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD147-targeting siRNA inhibits cell-matrix adhesion of human malignant melanoma cells by phosphorylating focal adhesion kinase.
    Nishibaba R; Higashi Y; Su J; Furukawa T; Kawai K; Kanekura T
    J Dermatol; 2012 Jan; 39(1):63-7. PubMed ID: 21967109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Integrin β1 as a Novel PAG1-Interacting Protein Involved in the Inherent Radioresistance of Human Laryngeal Carcinoma.
    Dong X; Luo Z; Liu T; Chai J; Ke Q; Shen L
    J Cancer; 2018; 9(22):4128-4138. PubMed ID: 30519312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A9 promotes prostate cancer cell invasion by activating TLR4/NF-κB/integrin β1/FAK signaling.
    Lv Z; Li W; Wei X
    Onco Targets Ther; 2020; 13():6443-6452. PubMed ID: 32884282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular gamma-synuclein promotes tumor cell motility by activating β1 integrin-focal adhesion kinase signaling pathway and increasing matrix metalloproteinase-24, -2 protein secretion.
    Liu C; Qu L; Zhao C; Shou C
    J Exp Clin Cancer Res; 2018 Jun; 37(1):117. PubMed ID: 29903032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAG1 promotes the inherent radioresistance of laryngeal cancer cells via activation of STAT3.
    Shen L; Ke Q; Chai J; Zhang C; Qiu L; Peng F; Deng X; Luo Z
    Exp Cell Res; 2018 Sep; 370(1):127-136. PubMed ID: 29913153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
    Mol Cancer; 2005 Oct; 4():37. PubMed ID: 16209712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A diterpenoid compound, excisanin A, inhibits the invasive behavior of breast cancer cells by modulating the integrin β1/FAK/PI3K/AKT/β-catenin signaling.
    Qin J; Tang J; Jiao L; Ji J; Chen WD; Feng GK; Gao YH; Zhu XF; Deng R
    Life Sci; 2013 Nov; 93(18-19):655-63. PubMed ID: 24044886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of HAb18G/CD147 promotes invasion and metastasis via alpha3beta1 integrin mediated FAK-paxillin and FAK-PI3K-Ca2+ pathways.
    Tang J; Wu YM; Zhao P; Yang XM; Jiang JL; Chen ZN
    Cell Mol Life Sci; 2008 Sep; 65(18):2933-42. PubMed ID: 18695939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin-specific control of focal adhesion kinase and RhoA regulates membrane protrusion and invasion.
    Costa P; Scales TM; Ivaska J; Parsons M
    PLoS One; 2013; 8(9):e74659. PubMed ID: 24040310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous β1 integrin-EGFR targeting and radiosensitization of human head and neck cancer.
    Eke I; Zscheppang K; Dickreuter E; Hickmann L; Mazzeo E; Unger K; Krause M; Cordes N
    J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25663685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple-negative mouse breast cancer initiating cells show high expression of beta1 integrin and increased malignant features.
    Fu J; Peng S
    Open Life Sci; 2023; 18(1):20220510. PubMed ID: 36879644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of uPAR retards radiation-induced invasion and migration mediated by integrin β1/FAK signaling in medulloblastoma.
    Nalla AK; Asuthkar S; Bhoopathi P; Gujrati M; Dinh DH; Rao JS
    PLoS One; 2010 Sep; 5(9):e13006. PubMed ID: 20886051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblast-derived Lumican promotes gastric cancer progression via the integrin β1-FAK signaling pathway.
    Wang X; Zhou Q; Yu Z; Wu X; Chen X; Li J; Li C; Yan M; Zhu Z; Liu B; Su L
    Int J Cancer; 2017 Sep; 141(5):998-1010. PubMed ID: 28542982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.